What Are the Most Common GLP-1 Side Effects and When Do They Happen?
Author
glp winnerDate Published
- Twitter
- Facebook
- LinkedIn
- Instagram
- Copy Link
The most common GLP-1 side effects are nausea, diarrhea, vomiting, constipation, and stomach discomfort, and they usually happen during the first few weeks after starting or increasing the dose.
If you are considering a GLP-1 medicine, it is completely normal to wonder, “How bad will this make me feel?” Most people tolerate these medicines well. Some have temporary digestive symptoms. A smaller group decides the symptoms are not worth continuing.
This guide walks through what is common, how often it happens, when it usually starts, and what helps.
At GLP Winner, we focus on helping you compare FDA-approved options and see how different providers handle dose increases and follow-up support. To get started, answer a few questions here to see your personal provider results.
First, What Are GLP-1 Medicines?
GLP-1 receptor agonists are medicines that copy a natural hormone in your body that helps control blood sugar and appetite (Cleveland Clinic). They also slow how quickly food leaves your stomach.
That slowing effect is why most side effects involve digestion, but it’s also a large part of how the drug helps the body regulate.
Ozempic contains semaglutide, which the FDA label describes as a human GLP-1 receptor agonist (Ozempic Prescribing Information).
Mounjaro contains tirzepatide, which the label describes as a dual GIP and GLP-1 receptor agonist (Mounjaro Prescribing Information).
Because these medicines work in the gut, early stomach symptoms are common and expected, but that doesn’t mean they are impossible to work with.
The Most Common GLP-1 Side Effects
Below are the symptoms people ask about most, and you’ll hear the most about in the news. For each one, you will see:
- How common it is
- When it usually happens
- What may reduce it
The percentages below come from large clinical trials of FDA-approved GLP-1 medicines, check out the links for more information about each.
1. Nausea
How common is it?
In weight management trials of semaglutide 2.4 mg, about 44% of patients reported nausea compared to 17% on placebo (Wegovy Prescribing Information).
With tirzepatide for weight management, nausea occurred in 24% to 33% depending on dose (Zepbound Prescribing Information).
When does it happen?
Nausea is most common during the first 4 to 8 weeks and during dose increases. It usually improves over time as the body adjusts (Wegovy Prescribing Information).
How long does it last?
The good news is this symptom seems to go away once your body adjusts to the medication. In trials, nausea was typically mild to moderate and decreased as treatment continued (Wegovy Prescribing Information).
What may reduce it?
- Eating smaller meals
- Avoiding high-fat meals
- Slower dose increases under provider guidance
Many providers use gradual dose change schedules specifically to reduce nausea, so if you feel like this is a big one for you, speak with your provider about starting on a low dose and moving up very cautiously.
For most people, nausea is uncomfortable but temporary. A smaller percentage stop treatment because of it.
2. Diarrhea
How common is it?
In semaglutide weight management trials, diarrhea was reported in about 30% of patients compared to 16% on placebo (Wegovy Prescribing Information).
With tirzepatide, diarrhea occurred in 18% to 23% depending on dose (Zepbound Prescribing Information), so slightly less often.
When does it happen?
Diarrhea often appears early, especially during the first dose increase, so generally you’ll find out if you’re affected right away.
What helps?
- Staying hydrated
- Avoiding greasy foods
- Gradual dose escalation
For most people, diarrhea improves over time as your body adjusts, but also can be helped by changing dosage more gradually over time.
3. Vomiting
How common is it?
Vomiting occurred in about 24% of patients on semaglutide 2.4 mg in weight management trials compared to 6% on placebo (Wegovy Prescribing Information).
With tirzepatide, vomiting ranged from 8% to 12% depending on dose (Zepbound Prescribing Information).
When does it happen?
Usually early, during dose escalation.
Important note:
If vomiting is persistent or severe, patients are advised to contact their provider because dehydration can occur (Ozempic Prescribing Information).
Vomiting is less common than nausea but tends to follow the same early pattern, so it’s also something that you can control with low and slow dose increases when working with your provider.
4. Constipation
How common is it?
Constipation occurred in about 24% of patients using semaglutide for weight management (Wegovy Prescribing Information).
Rates for tirzepatide range from 11% to 17% depending on dose (Zepbound Prescribing Information).
When does it happen?
It may develop after appetite decreases and food intake changes.
What helps?
- Adequate hydration
- Fiber intake
- Physical activity
The great news is this is one symptom that you have the ability to control yourself, since constipation often responds to basic lifestyle adjustments. Take a look at your eating habits and physical activity to get a better handle on this, which can also contribute to healthy habits that will pay off in the long run.
5. Stomach Pain or Indigestion
Abdominal pain and indigestion were reported in clinical trials across GLP-1 medicines, generally in the 5% to 15% range depending on the specific product and dose (Mounjaro Prescribing Information).
These symptoms are usually mild and tied to slowed stomach emptying, so can be controlled both with eating healthy food on a regular schedule as well as low and controlled dose changes.
When Are Side Effects Most Likely?
Side effects are most likely:
- During the first month
- During each dose increase
- At higher maintenance doses
GLP-1 medicines are intentionally started at low doses and increased slowly to reduce these effects (Wegovy Prescribing Information). If you are more than two weeks following a dose change and still feel side effects that are impacting your life, be sure to speak to your provider to move you back down to a lower dose so your body can tolerate the medication better.
How Many People Stop Because of Side Effects?
In semaglutide weight management trials, about 6% to 7% of patients discontinued due to gastrointestinal side effects (Wegovy Prescribing Information).
That means the majority continued treatment despite early symptoms.
This is important context. Online discussions can make side effects sound universal and permanent. Clinical trial data shows most symptoms are manageable and improve.
It’s also important to note that, like all prescription medications, there will be risks and side effects that are taken into consideration when prescribing. Your provider would look at your overall health history and evaluate the potential benefits of the medication to outweigh the risks and side effects, which is the only way to be approved for the prescription.
Side effects are also somewhat in your control - if you feel like side effects are negatively impacting your life, speak with your provider to see how your dosage or medication can be adjusted for a better experience.
What About Serious Risks?
Serious risks listed in FDA labeling include pancreatitis, gallbladder disease, kidney injury, and thyroid C-cell tumors observed in rodent studies (Ozempic Prescribing Information).
These are uncommon, but important to know about. They are listed so patients and providers can monitor symptoms appropriately.
If someone experiences severe abdominal pain that does not go away, medical evaluation is recommended - talk to your provider right away.
Serious complications are rare, but awareness matters.
What About Compounded GLP-1 Products?
We hear a lot about compounded GLP-1s in this space as well, and they can be a great tool in your health journey, especially when special dosing or compounding may be needed. Compounded GLP-1 products are not FDA-approved finished drugs, and the FDA says companies cannot market them as “generic” or “the same as” FDA-approved drugs (FDA Enforcement Statement).
At the same time, licensed compounding pharmacies operate under federal frameworks known as Section 503A and 503B. Section 503A pharmacies are regulated primarily by state boards of pharmacy, and Section 503B outsourcing facilities are subject to FDA inspection and current good manufacturing practice standards (FDA Compounding Overview). These facilities do need to meet certain requirements and safety standards to be in operation.
Some patients and clinicians use compounded GLP-1 products when individualized dosing, customized titration schedules, or specific formulation adjustments are medically appropriate. Any compounded medication should be prescribed by a licensed clinician and prepared by a properly licensed and inspected facility.
If you feel like compounded medications may be a good fit for you, be sure to discuss them with your provider to see if they’d recommend them.
Final Takeaway
Most GLP-1 side effects involve the stomach. That makes sense, because these medicines slow digestion and change how your body handles food.
For many people, symptoms show up in the first few weeks or when the dose increases. That early phase is usually the hardest part. As the body adjusts, things often settle down.
Some people decide the side effects are not worth it for them. That is a personal call, and it is okay.
The helpful part is knowing what is common and when it tends to happen. When you see the real numbers and the typical timeline, it feels less unpredictable. And when something feels less unpredictable, it usually feels less scary.
If you enjoy posts like these, you can subscribe to receive newsletter updates.
Sources
Keep Reading
Learn which risks are real, which are exaggerated, and what most people actually experience over time.
Certain foods can worsen nausea, bloating, and reflux on GLP-1 medications. Learn which foods often trigger symptoms and which tend to help.
Worried about GLP-1 side effects like stomach paralysis or “Ozempic face”? This guide debunks myths with real research and clear answers.
Curated by
